Omeros (OMER) Operating Leases (2018 - 2026)
Omeros' (OMER) quarterly Operating Leases came in at $5.6 million in Q1 2026, down 53.13% year-on-year from $11.9 million in Q1 2025, and down 22.75% quarter-over-quarter from $7.2 million in Q4 2025.
Omeros (OMER) Operating Leases (2018 - 2026) Analysis & Trends
Omeros has disclosed Operating Leases across 9 years of filings, most recently posting $5.6 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $5.6 million, down 53.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (down 53.13% YoY), and the FY2025 annual result was $7.2 million, down 46.2% from the prior year.
- Operating Leases came in at $5.6 million for Q1 2026 at Omeros, down from $7.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $24.5 million in Q2 2022 to a low of $5.6 million in Q1 2026.
- The 5-year median for Operating Leases is $16.8 million (2024), against an average of $16.4 million.
- Across the five-year window, Operating Leases decreased 12.38% in 2023 and plunged 53.13% in 2026, its largest moves.
- Omeros' Operating Leases stood at $22.4 million in 2022, then retreated by 19.1% to $18.1 million in 2023, then dropped by 25.78% to $13.5 million in 2024, then slumped by 46.2% to $7.2 million in 2025, then decreased by 22.75% to $5.6 million in 2026.
- The last three Operating Leases figures came in at $5.6 million (Q1 2026), $7.2 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.60 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 10.38 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 14.24 Mn |
| Jun 30, 2024 | 15.63 Mn |
| Mar 31, 2024 | 16.75 Mn |
| Dec 31, 2023 | 18.14 Mn |
| Sep 30, 2023 | 19.25 Mn |
| Jun 30, 2023 | 20.42 Mn |
| Mar 31, 2023 | 21.29 Mn |
| Dec 31, 2022 | 22.43 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 24.52 Mn |
| Mar 31, 2022 | 24.30 Mn |
| Dec 31, 2021 | 34.38 Mn |
| Sep 30, 2021 | 30.29 Mn |
| Jun 30, 2021 | 31.41 Mn |